Drug Watch. Rare cancers.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 102
- Publication type:
- Article
Works matching IS 1082801X AND DT 2011 AND VI 46 AND IP 3
Results: 9
1
2
Policy Watch. Health system databases support comparative studies, quality assessment, and regulatory decision-making.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 100
- By:
- Publication type:
- Article
3
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 99
- Publication type:
- Article
4
FDA Drug Approvals. First-time generic approvals.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 99
- Publication type:
- Article
5
FDA Drug Approvals. New molecular entity.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 98
- Publication type:
- Article
6
FDA Drug Approvals. New formulation.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 98
- Publication type:
- Article
7
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 98
- Publication type:
- Article
8
Treatment of bipolar disorder: A focus on medication therapy for mania.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 82
- By:
- Publication type:
- Article
9
Ceftaroline: A novel cephalosporin with methicillin-resistant Staphylococcus aureus and multidrug-resistant Streptococcus pneumoniae activity.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 71
- By:
- Publication type:
- Article